SOURCE: ISTA Pharmaceuticals

ISTA Pharmaceuticals

February 09, 2011 07:30 ET

ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2010 Financial Results

IRVINE, CA--(Marketwire - February 9, 2011) - ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will release fourth quarter and full-year 2010 financial results after the market closes on February 23, 2011. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time. 

 Date: Wednesday, February 23, 2011
 Time: 4:30 p.m. Eastern Time

Conference call access:
Domestic dial-in: 866-770-7120
International dial-in: 617-213-8065
Passcode: 66872732

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 11293297. This conference call also will be webcast live and archived on ISTA's website until March 23, 2011.

About ISTA Pharmaceuticals
ISTA Pharmaceuticals, Inc., is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets five products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain and nasal allergies. Headquartered in Irvine, California, the Company generated 2009 revenues of $111 million. For additional information about ISTA Pharmaceuticals, please visit the corporate website at

Contact Information